Resource Center
Explore Resource Types
Focused Solutions
Biologics
Make advancements with precision biologics tools, designed to enhance your therapeutic approaches encompassing monoclonal antibodies, recombinant proteins, vaccines, and targeted next-generation cell and gene therapies.
Cell and Gene Therapy
The recent success of cell and gene therapies has paved the way for the next generation of advanced therapeutics. While challenges remain, cell and gene therapy research is seeing a transformational shift in the way that novel modalities, such as CAR-T, CRISPR, and vectors, are developed and delivered.
Disease Research
New drug modalities and targets are enabling us to live longer and healthier lives— but their development is grounded on a deep understanding of disease onset and progression.
Drug Development
The process of drug development comprises all the activities involved in bringing a new drug to market once a lead compound has been identified.
Functional Genomic Screening
Identify and characterize drug discovery targets with functional genomic screening services. Offering CRISPR knockout, CRISPR activation, CRISPR inhibition, dual screening and RNAi technologies
Integrated Lab Automation
From cellular screening and imaging applications to high-throughput screening and genomics-based applications, custom explorer™ G3 integrated workstations
Physiological Model Solutions
Drug discovery endeavors require a deep understanding of biological systems and their response to potential therapeutics.
Precision Medicine Research
Countless diseases, especially cancer, are highly heterogenous in nature which means a one-drug-fitsall approach isn’t practical for treating or fighting these diseases effectively.
Small Molecule Drug Discovery
With decades of experience in drug discovery driven by strong customer relationships, Revvity has developed an excellent product portfolio of drug discovery tools for complete solutions serving all parts of the discovery workflow.
All Resources
Filters
205 - 216 of 975 Results
White paper: The historical development of the hemocytometer
White paper describing the historical development of hemocytometer.
Therapeutic development with robust cellular binding assays.
From the chemistry of our assays to the collaborative nature of our relationship
Determination of the 3H, Gross α/β and 222Rn Activity Concentration in Drinking Water with the…
The analysis of drinking water has been the focus of many laboratories
LANCE Ultra cAMP: a new TR-FRET cAMP assay for Gs - and Gi-coupled receptors.
We have developed a second-generation LANCE® time-resolved fluorescence
Cellometer X2 fluorescent cell viability counter brochure
Brochure describing the Cellometer X2 fluorescent cell viability counter.
Complete Virology Solutions Infographic
Virology solutions to enable virus monitoring, detection neutralization testing
Optimization and pharmacological validation of wild type beta-arrestin 2 plasmid transfection.
In this note, we cover the best practices and elements that can be monitored and
Measurement of p38/MAPK Activity Using LANCE
This note presents a method to evaluate inhibitors of p38 kinase activity using
DELFIA immunoassay development guide
DELFIA immunoassays are a superior alternative to traditional ELISAs
Imaging and gene editing approaches highlight important role of autophagy in controlling Mtb…
Learn how researchers used CRISPR-Cas9 gene editing and high-content imaging
Multiplex 2D imaging of NIR molecular imaging agents on the IVIS SpectrumCT platform
Multiplex 2D in vivo imaging of IVISense™ NIR fluorescent agents using the IVIS®
Low input PCR-free DNA-seq library prep and normalization
Low input PCR-free DNA-seq library prep and normalization
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.